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Introduction
Integrins are the major adhesion receptors of hematopoietically-derived cells. The ability of leukocytes to use the integrins LFA-1 and α4β1 to leave the circulation and migrate into tissues is critical for a successful immune response [1, 2] . Platelets use integrins, particularly αIIbβ3, to bind fibrinogen which is essential for clotting [3] . The integrins on circulating leukocytes and platelets normally bind poorly to their ligands, but become active following "inside-out" signalling through other membrane receptors [2, 4, 5] .
Important features of the signalling pathway leading to integrin activation are now understood. Diacylglycerol and Ca 2+ , which are the products of agonist signalling, activate protein kinase C and/or the Rap1 guanine nucleotide exchange factor, CalDAG-GEF1. These proteins promote activation of Rap1 that is brought to the membrane by the adaptor protein Rap1-GTP-Interacting Adapter Molecule (RIAM) [6] [7] [8] . Another critical step involves the recruitment of talin to the RIAM/Rap1 complex bringing it into position to bind to the β subunit of integrins. This binding stabilises the conformation of integrin with highest affinity for ligand [9] [10] [11] .
Recently it has been recognized that the three members of the kindlin family are also involved in integrin activity [12, 13] . Each has a distinctive tissue distribution: kindlin-1, epithelial expression; kindlin-2, muscle and more widespread expression and kindlin-3, haematopoietic specific. Both talin and the kindlins have similar FERM (protein 4.1, ezrin, radixin and moesin) domain structures. FERM sub-domain 3 of these proteins binds the β subunit of integrins -talin at the membrane-proximal NXXY site and the kindlins at the membrane-distal NXXY site [14] [15] [16] . The kindlins differ from talin in having 
Antibodies and other reagents
MAbs 38 (αL, CD11a), TS1/18 (β2, CD18), HP2/1 (α4, CD49d) and P5D2 (β1, CD29) have been previously reported [24, 32] . Other Abs were affinity purified rabbit polyclonal serum specific for human kindlin-3 peptide (EPEEELYDLSKVVLA; amino acids 156-170)[27] and anti-α-tubulin mAb (Sigma-Aldrich). Horseradish peroxidase-coupled anti-GFP mAb was purchased from Miltenyi Biotech. Full length ICAM-1Fc protein was prepared as previously described [24] .
Mutation of human KINDLIN3 cDNA
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Human KINDLIN3 was obtained by PCR from a full-length cDNA clone, IRAUp969A0924D (ImaGenes). A 5' HindIII site was added using oligo GCCAAGCTTATGGCGGGGATGAAG and a 3' AgeI site added using oligo TCAACCGGTCCTGCGAAGGCCTCATGGCC. The PCR product was subcloned into vector pEGFP-N1 (Clontech). The G>A and ΔT mutations were made in WT KINDLIN3-GFP using QuikChange Site-directed Mutagenesis Kit (Stratagene). Forward and reverse primers containing the sequence CTGTCCCAGAGCAGGGAGGTGGGGG for the G>A mutation and TAGTGCCCTCCCCGAGGGCATGAGT for the ΔT mutation were used. The G>A and ΔT double mutated construct was made by adding the G>A mutation to ΔT KINDLIN3-GFP using the same oligos and protocol as for WT KINDLIN3. All DNA constructs were verified by sequencing.
The murine pEGFP-kindlin3 DNA construct was previously described [12, 27] .
Sequencing the KINDLIN3 gene
Genomic DNA from the patient, her mother and non-related controls was analyzed for base changes in all exons and intron-exon boundaries of the 
Flow cytometry
Leukocytes (5x10 5 ) were incubated on ice in 50 μl of PBS/0.2% BSA containing primary mAb at optimal dilution as described previously [24] . Bound mAb was detected with FITC-conjugated goat anti-mouse IgG (Sigma) and analyzed by FACS Calibur (BD Biosciences).
Cell attachment assays
Flat-bottom Immulon-1 96 well plates were coated with 50 μl ICAM-1Fc (3 μg/ml) or fibronectin (10 μg/ml) in PBS overnight at 4°C and blocked with ) were lysed in 0.5ml buffer (1% Triton X-100, 50 mM Tris-base pH 7.5, 150 mM NaCl and complete protease inhibitor cocktail (Roche Diagnostics Ltd.). Cell lysate proteins were reduced in 2x Laemmli buffer and separated using pre-cast 3-8% SDS-PAGE gels (Invitrogen), then transferred to PVDF membrane (Immobilon-P, Millipore). Blots were probed with primary Abs as specified and detected with goat anti-rabbit IgG-HRP (Dako) or sheep anti-mouse Ig-HRP and ECL detection reagents (GE Healthcare).
Video microscopy
μ-Slides VI (ibidi, Thistle Scientific) were coated overnight with 50 μl of 3 μg/ml ICAM-1Fc then blocked with 2% BSA. FACS-sorted B lymphocytes 
Live cell imaging of GFP-kindlin-3
FACS-sorted B cells at 1 x 10 6 cells/ml were added to ICAM-1Fc-coated μ-Slides VI dishes as described above. Images were taken using a For evaluation of adhesion status, the area of contact was measured using MetaMorph Offline 7.1.
Statistical analysis
The adhesion and migration assays are presented as the mean ± SEM.
The unpaired Student's t test was performed on the IRM data using GraphPad Prism software version 4 for Macintosh computers. The qRT-PCR data was analysed using the two-way ANOVA test and the migration data was analysed using a one-way ANOVA test. The following significant differences are as indicated: *, p<0.05; **p<0.01; and ***, p<0.001.
Results

Characterization of a new LAD-III patient of African-American origin
The patient is an 11 month old African-American female with a severe bleeding tendency from birth and an elevated white blood cell count with persistent Gram-positive and -negative bacterial infections requiring hospitalization. These symptoms resembled a combination of Glanzmann's For personal use only. on October 3, 2017. by guest www.bloodjournal.org From thrombasthenia (GT), where platelets fail to aggregate due to mutations in the β3 integrin, αIIbβ3, and LAD-I where mutation in the β2 subunit causes lack of expression of β2 integrins leading to impaired leukocyte extravasation [33] .
This combination of disease characteristics is typical of LAD-III. However, a key feature distinguishing LAD-III from GT and LAD-I is the normal expression, but lack of function, of β1, β2 and β3 subclasses of integrins on cells of haematopoietic origin [34] .
We therefore investigated LFA-1 (αL and β2 subunits) and α4β1 (α4 and β1 subunits) that are major integrins on T cells and found comparable expression between the LAD-III patient, control ( (Fig. 1B) . Stimulation of adhesion with Mg 2+ /EGTA that activates integrins from "outside" the cell, showed that the integrins expressed by the LAD-III T cells were capable of adhesion.
These findings were reinforced by the observation that the mother's T cells adhered and spread on ICAM-1 in a typical LFA-1-dependent manner, in contrast to the patient's T cells that were unable to spread (Fig. 1C) .
Therefore the patient's T cells exhibit typical characteristics of the LAD-III disorder.
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Assessment of mutations in the KINDLIN3 gene
Sequencing of the KINDLIN3 genomic DNA revealed that the patient had two homozygous base changes at positions where the mother displayed heterozygosity and these changes did not correspond to known polymorphisms in the KINDLIN3 gene. Furthermore, sequencing of all 15 exons and the intron/exon boundaries of the KINDLIN3 gene of the patient and her mother yielded no further unexpected mutations (data not shown but available on request).
The first mutation was a G>A base substitution at position 922 in exon 8 predicted to cause an amino acid alteration of Gly308Arg ( Fig. 2A) . The Gly308Arg change is located in the loop linking the first half of FERM subdomain 2 and the PH domain (Fig. 4) . The second mutation consisted of a single nucleotide deletion of 1275T (ΔT) in exon 11 causing a shift in the triplet reading frame and generating an in-frame TGA termination codon after a further seven nucleotides (Fig. 2B) . Thus premature termination will follow Pro425 after addition of two novel amino acids (Pro425GluGly>ProArgAlaX). This mutation is within the PH domain in the loop between the β6 and β7 strands and the first to be described in this kindlin-3 domain (Supplemental
Fig. 1).
Quantitative RT-PCR was used to investigate the effect of these base changes on expression of patient KINDLIN3 mRNA isolated from T lymphoblasts. We used TaqMan probes specific for exons 6-7 that preceed, and for exons 13-14 that follow, the mutation sites. (Fig. 2C) . The effect of the mutations was to cause unstable KINDLIN3 mRNA leading to its destruction presumably by nonsense mediated decay (NMD).
We then investigated the levels of T lymphoblast kindlin-3 protein by Western blot analysis. No kindlin-3 protein was detected in the patient T cells, whereas it was detected in the mother's T cells, but at a reduced amount compared to control T cells (Fig. 2D) . Therefore, as expected, the lack of KINDLIN3 mRNA meant that no kindlin-3 protein was made.
The effect of transfection of WT KINDLIN3 cDNA on LAD-III T lymphocyte adhesion
As we were investigating a LAD-III patient from a new ethnic background, it was necessary to prove that the inability of lymphocytes to adhere was due to a faulty KINDLIN3 gene. We therefore transfected the patient's T lymphoblasts with mouse WT kindlin3 cDNA as previously described[27] and used interference reflection microscopy (IRM) to assess the level of close contact of the cells with ICAM-1 as a measure of the extent of adhesion (Fig. 3A) . (Fig. 3B) .
Therefore the failure of the patient's T cells to adhere to ICAM-1 could be As the two new LAD-III mutations were in domains of the kindlin-3 protein about which there is little information, it was of interest to know whether they would affect the function of this protein in vitro. As well as human WT KINDLIN3, three separate mutant KINDLIN3 cDNAs were generated in a GFP-vector (Fig. 4) . One mutant construct contained the G>A base change located at the end of the first half of FERM sub-domain 2 giving rise to kindlin-3 protein expressing Gly308Arg. The second construct contained the deletion of T1275 in the PH domain and was designed to give rise to a protein truncated following Pro425ArgAlaX. The third construct incorporated both of the mutations (Double mutant).
To gain some insight into whether kindlin-3 had a role at the level of the lymphocyte membrane, we transfected patient EBV-transformed B cells with WT KINDLIN3-GFP cDNA, the three mutant KINDLIN3-GFP cDNAs and GFP cDNA as a control (Fig. 5) . The cells were FACS-sorted using GFP to be certain that similar levels of kindlin-3-GFP protein were expressed in each transfectant (data not shown). Western blotting confirmed the expression of GFP, kindlin-3-GFP WT and mutant proteins and that the proteins were of expected molecular size (Fig. 5B) .
We then viewed the cells by confocal microscopy after 20 min migration on immobilized ICAM-1. Punctate staining was visible at the (Fig. 5A) . Therefore WT kindlin-3-GFP was expressed at membrane level and this localisation was not affected by the Gly308Arg mutation, but was prevented by the Pro425ArgAlaX mutant that was truncated in the PH domain. (Fig. 6A) . This was also reflected in their inability to migrate, resulting in a floating cell phenotype ( Fig. 6B) (Supplemental Movie, Fig6Bvideo1.avi) . Transfection of B cells with WT KINDLIN3 cDNA restored the ability to adhere both at a single cell level and when the area of attachment was quantified (Fig. 6A) .
Random migration on ICAM-1 could also be restored by transfection of the cells with WT KINDLIN3 cDNA (Fig. 6B) (Supplemental Movie,
Fig6Bvideo2.avi).
In terms of the LAD-III B cells transfected with the mutated constructs, Gly308Arg KINDLIN3 restored cell adhesion comparably to WT KINDLIN3 (Fig. 6A) . However this same transfectant had significantly reduced levels of migration compared with WT KINDLIN3-transfected LAD-III B cells ( Fig. 6B; For personal use only. 
5.avi). A model of the kindlin-3 PH domain is shown with the location of
Pro425ArgAlaX in the β6 to β7 loop indicated (Fig. 6C) . We compared the FERMT3/kindlin-3 PH domain with PH domains expressing both canonical and non-canonical PI binding sites ( Supplemental Fig 1)[19, 20] . The kindlin-3 PH domain displays all the key conserved residues of the canonical binding site, indicating that it will bind phosphoinositides. A dendrogram of relatedness to other canonical PH domain-containing proteins shows it to most closely resemble BTK, PDK1 and PLCδ1, key immune cell mediators (Supplemental Fig. 2) . Thus an explanation for the lack of association of Pro425ArgAlaX kindlin-3 with the membrane is that the truncated PH domain is no longer capable of membrane anchoring.
Discussion
We describe here a new LAD-III patient of African-American origin who, unlike previously described LAD-III patients, expresses two homozygous An issue of interest is the inheritance of the two homozygous KINDLIN3 mutations. One option is that they have co-evolved and a second is that they have arisen separately and become linked in the African-American population to which our patient and her heterozygous mother belong.
Population screening would be required to investigate the frequency of the two KINDLIN3 mutations within this group. The LAD-III disease characteristics of the patient are particularly severe [31] . For example the patient displayed extensive osteopetrosis that has also been a feature of the kindlin-3 -/-mice [15] . This has so far been detailed for one other LAD-III patient with a mutation in the kindlin-3 F0 sub-domain [29] . Differences in disease severity between LAD-III patients may depend on their genetic backgrounds. However it is also possible that the nature of the KINDLIN3 mutation may play a role potentially giving rise to small amounts of mutated protein in vivo that are difficult to detect in vitro. As the two mutations of the African-American patient affect both adhesion-dependent as well as adhesion-independent functions in in vitro assays, they might be particularly debilitating in terms of disease.
Therefore there may be heterogeneity in the LAD-III disorder that is dependent on the location of the KINDLIN3 mutations.
The lack of patient KINDLIN3 mRNA indicates that the mutations caused instability and subsequent loss through NMD. However we reasoned that KINDLIN3 cDNA constructs containing the individual mutations would be resistant to NMD because of their lack of introns [35, 36] and give rise to For personal use only. on October 3, 2017. by guest www.bloodjournal.org From response to Mn 2+ that induces the αIIbβ3 integrin to bind ligand, platelets are able to attach, but are unable to spread like kindlin-3 +/+ platelets [15] .
Other than integrin binding, the contributions that the individual kindlin FERM subdomains might make to adhesion or migration have not been clearly defined. The kindlins are regarded essentially as scaffold proteins lacking domains with intrinsic activity. To date integrin linked kinase has been identified as a binding partner of UNC112, the kindlin homologue in C.
elegans [38] and kindlin-2 in fibroblasts [39] . The filamin-binding protein, migfilin, also binds to kindlin-2 [40] . Both could potentially provide a link to the actin cytoskeleton, but so far there is no information as to how these proteins interact with the kindlin structure [13, 41] . 
